Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
RARRES3 Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody
Supplier: Novus Biologicals NBP159395
Description
RARRES3 Polyclonal specifically detects RARRES3 in Human samples. It is validated for Western Blot, Immunohistochemistry, Immunohistochemistry-Paraffin.Specifications
RARRES3 | |
Polyclonal | |
Unconjugated | |
PBS, 2% Sucrose with 0.09% Sodium Azide | |
HRASLS4, PLA1/2-3, RAR-responsive protein TIG3, retinoic acid receptor responder (tazarotene induced) 3, retinoic acid receptor responder protein 3, retinoic acid-inducible gene 1, Retinoid-inducible gene 1 protein, RIG1, Tazarotene-induced gene 3 protein, TIG3MGC8906 | |
Rabbit | |
Protein A purified | |
RUO | |
Primary | |
Expected identity based on immunogen sequence: Human: 92%. | |
Human | |
Purified |
Western Blot, Immunohistochemistry, Immunohistochemistry (Paraffin) | |
1 mg/ml | |
Western Blot 1.0 ug/ml, Immunohistochemistry 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500 | |
Q9UL19 | |
RARRES3 | |
Synthetic peptides corresponding to RARRES3(retinoic acid receptor responder (tazarotene induced) 3) The peptide sequence was selected from the middle region of RARRES3. Peptide sequence FSVLSNSAEVKRERLEDVVGGCCYRVNNSLDHEYQPRPVEVIISSAKEMV. | |
100 μL | |
Tumor Suppressors, Vision | |
5920 | |
Centrifuge the vial of lyoph antibody at 12,000 x g for 20 seconds. Add 100μL of distilled water. Vortex followed by centrifuge again to pellet the solution.Final concentration is 1mg/mL in PBS buffer. | |
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. | |
IgG |
Product Suggestions
Customers who viewed this item also viewed
Viewing 1-5 of 8
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
RARRES3 Antibody, Novus Biologicals™ > 100μL; Unlabeled
Spot an opportunity for improvement?Share a Content Correction